Hybrid Pharma, LLC
FDA 503B outsourcing facility
Deerfield Beach, Florida
Key Takeaways
- FDA-registered 503B outsourcing facility since 2015
- Sterile compounding from bulk substances: Yes
- Last FDA inspection: November 9, 2023
About this facility
A 503B outsourcing facility is registered with the FDA under the Drug Quality and Security Act and may compound sterile medications in bulk without patient-specific prescriptions, under cGMP manufacturing standards. How federal compounding status works.
FDA registration and inspection record
- First registered with FDA
- January 14, 2015
- Most recent registration
- December 16, 2025
- Compounds sterile drugs from bulk substances
- Yes
- Last FDA inspection
- November 9, 2023
The FDA last inspected Hybrid Pharma, LLC on November 9, 2023. Investigators issued a Form FDA 483 listing inspectional observations at that visit. The FDA has not yet determined whether further action will be taken.
What this facility compounds
Hybrid Pharma, LLC reports compounding 74 distinct active ingredients to the FDA Outsourcing Facility Product Report (most recent reporting periods).
Tracked on PeptideGrids: Glutathione, Semaglutide, Sermorelin, Tirzepatide.
- Alcohol
- Alpha Lipoic Acid
- Alprostadil; Papaverine Hydrobromide; Phentolamine Mesylate
- Amphotericin B; Clioquinol
- Amphotericin B; Sulfamethoxazole; Chloramphenicol
- Arginine
- Arginine Hydrochloride
- Arginine Hydrochloride; Carnitine; Glutamine
- Ascorbic Acid
- Benzocaine
- Benzocaine; Tetracaine; Lidocaine
- Biotin
- Buprenorphine Hydrochloride
- Calcium Gluconate Monohydrate
- Carnitine
- Ciprofloxacin; Dexamethasone; Clotrimazole
- Clotrimazole; Ciprofloxacin; Dexamethasone
- Cyanocobalamin
- Diclofenac Sodium
- Diltiazem Hcl
- Dimethyl Sulfoxide
- Doxycycline Hyclate
- Epinephrine; Tetracaine; Lidocaine Hydrochloride
- Estradiol
- Estriol
- Estriol; Testosterone; Estradiol
- Estriol; Testosterone; Estradiol; Progesterone
- Glutamine
- Glutathione
- Glycine
and 44 more.
Location
1015 W Newport Center Dr, Deerfield Beach, FL 33442
Satellite and street imagery via Esri. Open larger map.
Contact
FDA-registered contact: Ponswamy Rajalingam, 954-708-2771. Source: the facility's FDA outsourcing registration.
License verification
503B outsourcing facilities are also licensed by the state board of pharmacy. Verify the current license status of Hybrid Pharma, LLC with the Florida Board of Pharmacy.
503B facilities in Florida
Florida has 16 FDA-registered 503B outsourcing facilities in the PeptideGrids directory. See all 503B facilities in Florida.
Frequently asked questions
Is Hybrid Pharma, LLC registered with the FDA?
Yes. Hybrid Pharma, LLC is a registered 503B outsourcing facility, first registered with the FDA on January 14, 2015 and most recently registered on December 16, 2025.
Has Hybrid Pharma, LLC been inspected by the FDA?
The FDA last inspected Hybrid Pharma, LLC on November 9, 2023. A Form FDA 483 was issued.
Has Hybrid Pharma, LLC had any FDA drug recalls?
No FDA drug recalls are matched to Hybrid Pharma, LLC in the openFDA enforcement database.
What does Hybrid Pharma, LLC compound?
Hybrid Pharma, LLC reports compounding 74 active ingredients to the FDA, including Glutathione, Semaglutide, Sermorelin, Tirzepatide.
Where is Hybrid Pharma, LLC located?
Hybrid Pharma, LLC is located in Deerfield Beach, Florida (1015 W Newport Center Dr).
Registration and inspection data verified against the FDA list of registered outsourcing facilities on June 6, 2026.
PeptideGrids is independent and not affiliated with, endorsed by, or sponsored by Hybrid Pharma, LLC. Listings, registration, inspection, and recall data are reported from public FDA records for informational purposes only. A recall or inspection finding is not an accusation of current wrongdoing. This is not medical or legal advice. To request a correction, see our corrections policy.